Hy-Gro Chemicals Pharmtek
Hy-Gro Chemicals Pharmtek is a privately held Indian manufacturer of Active Pharmaceutical Ingredients and advanced intermediates for global pharmaceutical companies, operating two cGMP facilities (588KL reactor capacity) approved by USFDA, EDQM, PMDA, and MFDS, with exports to over 45 countries and a development pipeline in CNS, diabetes, and urology therapeutics.
- Company typePrivate
- Founded1970
- HeadquartersSecunderabad, India
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hy-Gro Chemicals Pharmtek does
Hy-Gro Chemicals Pharmtek Pvt. Ltd is an India-based, privately held Active Pharmaceutical Ingredient (API) and advanced intermediates manufacturer serving global pharmaceutical formulators. The company was founded in the early 1970s as a trading business, entered bulk drug manufacturing as an associate concern in 1980, and established its first dedicated cGMP manufacturing facility at Bollaram, Telangana in 1995. A second greenfield facility at Jawaharlal Nehru Pharmacity, Visakhapatnam commenced operations in 2013, bringing combined reactor capacity to approximately 588 kiloliters across two ISO 9001/14001/45001-certified sites. The founder and owner is Vivek Bishnoi.
The company's core offering spans two product lines: (i) commercial APIs such as Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, Naproxen Sodium, Doxylamine Succinate, Diflunisal and Pyrathiazine Theoclate, plus a development pipeline including Mirabegron, Dapagliflozin, Vilazodone, Flibanserin, Sapropterin Dihydrochloride, and Dabigatran Etexilate Mesylate; and (ii) advanced intermediates including (S,S)-2,8-Diazabicyclo Nonane, 2-Methoxy Phenothiazine and Dextromethorphan Base. Manufacturing is underpinned by multi-step chemical synthesis capabilities (catalytic hydrogenations, asymmetric reductions, Grignard reactions, cyanation, azidation, etc.), a Quality-by-Design development methodology, and a 4,500 sq ft DST-recognized R&D laboratory with a pilot plant for scale-up. Facilities carry USFDA, EDQM, PMDA, MFDS, EU GMP (WCC), COPP, DCG(I) and CDSCO approvals, supporting exports to more than 45 countries across the USA, European Union, Japan, China, Korea, Taiwan, GCC, and Latin America.
Hy-Gro operates a B2B enterprise field-sales model, selling APIs and intermediates directly to global pharmaceutical companies through multi-year contracts with quote-based pricing. The company also offers custom synthesis and toll manufacturing services, monetizing spare R&D and reactor capacity for third-party molecules. Go-to-market relies on the corporate website, direct business inquiries, and prior trade-show participation (currently suspended due to COVID-19). Customer visibility into named accounts is limited, although Pfizer and Kenvue have conducted independent safety audits at the Bollaram facility. The company is privately held with no disclosed funding rounds, revenue figures, or institutional investors.
Hy-Gro Chemicals Pharmtek firmographics
Firmographics- Name
- Hy-Gro Chemicals Pharmtek
- Legal name
- Hy-Gro Chemicals Pharmtek Pvt. Ltd
- Website
- https://hygrochemicals.com
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hy-Gro Chemicals Pharmtek is a privately held Indian manufacturer of Active Pharmaceutical Ingredients and advanced intermediates for global pharmaceutical companies, operating two cGMP facilities (588KL reactor capacity) approved by USFDA, EDQM, PMDA, and MFDS, with exports to over 45 countries and a development pipeline in CNS, diabetes, and urology therapeutics.
- Ownership category
- akta.pro rank
Hy-Gro Chemicals Pharmtek industry classification
Industry- Product category
- Active Pharmaceutical Ingredients (APIs)
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541), Chemical Manufacturing (325)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Chemicals & Allied Products (2800)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industry
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
Keywords
Where Hy-Gro Chemicals Pharmtek is headquartered
LocationHeadquarters
- HQ city
- Secunderabad
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Hy-Gro Chemicals Pharmtek business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Infrastructure, Operations, Personnel, Technology or R&D, Supply Chain, Others
Revenue model
- API Manufacturing and Sales: Manufacture and sale of Active Pharmaceutical Ingredients (APIs) to global pharmaceutical companies. Products include Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, Naproxen Sodium, Doxylamine Succinate, Diflunisal, and Pyrathiazine Theoclate. Revenue generated through direct B2B sales with regulatory approvals (USDMF, CEP, DMF) enabling global market access.
- Advanced Intermediates Manufacturing: Manufacture and supply of advanced pharmaceutical intermediates for API synthesis. Products include (S,S)-2,8-Diazabicyclo Nonane for Moxifloxacin, 2-Methoxy Phenothiazine for Levomepromazine, Dextromethorphan Base, and intermediates for Dabigatran, Nelfinavir, Itraconazole, and Dapagliflozin.
- Custom Synthesis and Toll Manufacturing: Custom synthesis and toll manufacturing services for new products as per customer requirements. API development and manufacturing for global regulated and developing markets.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B enterprise pricing - custom quotes based on product specifications, volume requirements, and regulatory documentation needs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Hy-Gro Chemicals Pharmtek product offering
Product offeringCore offering
Hy-Gro Chemicals Pharmtek manufactures Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, and Specialty fine chemicals at two cGMP-compliant facilities in India. The company supplies products such as Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, Naproxen Sodium, Doxylamine Succinate, Diflunisal, and Pyrathiazine Theoclate to global pharmaceutical companies, along with intermediates for molecules including Moxifloxacin, Levomepromazine, Dabigatran, Nelfinavir, Itraconazole, and Dapagliflozin. It also offers custom synthesis and toll manufacturing services for new products developed to customer specifications.
Product overview
Hy-Gro Chemicals Pharmtek is a manufacturer of Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, and Speciality fine chemicals. The company operates two GMP-compliant manufacturing facilities in India and offers a product portfolio including Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, and related compounds, along with APIs under development such as Flibanserin, Mirabegron, and Dapagliflozin. The company also provides custom synthesis and toll manufacturing services through its dedicated R&D facility.
Differentiator
Problem solved
Functional benefit
Products and services
- Active Pharmaceutical Ingredients (APIs) Active Pharmaceutical Ingredients including Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, Naproxen Sodium, Doxylamine Succinate, Diflunisal, and Pyrathiazine Theoclate, supplied to global regulated and developing pharmaceutical markets for finished dosage form manufacturing.
- Advanced Intermediates Specialized intermediate compounds for pharmaceutical synthesis including (S,S)-2,8-Diazabicyclo Nonane for Moxifloxacin, 2-Methoxy Phenothiazine for Levomepromazine, Dextromethorphan Base, and intermediates for Dabigatran, Nelfinavir, Itraconazole, and Dapagliflozin.
- APIs Under Development Active pharmaceutical ingredients in the company's development pipeline including Flibanserin, Sapropterin Dihydrochloride, Mirabegron, Vilazodone, Dabigatran Etexilate Mesylate, Dexketoprofen Trometamol, and Dapagliflozin.
- Custom Synthesis and Toll Manufacturing Custom synthesis and toll manufacturing services for new products, developing advanced intermediates and APIs per customer specifications, leveraging multi-step chemical synthesis capabilities and the 4,500 sq. ft R&D laboratory with pilot plant for scale-up.
Companies that use Hy-Gro Chemicals Pharmtek
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Hy-Gro Chemicals Pharmtek technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hy-Gro Chemicals Pharmtek partnerships and signals
Strategic signalScale indicators6 records
Recent moves8 records
Expansion highlights5 records
Hy-Gro Chemicals Pharmtek competitors and assessment
Company assessmentDirect peers
- Neuland Laboratories: Indian API manufacturer and CDMO with similar scale, USFDA/EDQM approvals, and focus on small-molecule APIs for global generics. Closely aligned with Hy-Gro in capacity, therapeutic coverage, and customer profile.
- Divis Laboratories: Leading Indian API and intermediate manufacturer with strong presence in generics and custom synthesis. Highly comparable product portfolio (APIs, intermediates, custom synthesis) with similar regulatory approvals and customer base of global pharma.
- Aurobindo Pharma: Major Indian generic pharmaceutical and API manufacturer with global export footprint and USFDA/EDQM/PMDA approvals. Directly comparable to Hy-Gro in small-molecule API manufacturing for regulated markets, though operating at significantly larger scale.
- Sai Life Sciences: Indian CRAMS and API manufacturer with similar small-molecule capabilities, multi-step synthesis expertise, and global pharma customer base. Comparable CDMO/custom synthesis service offering alongside API manufacturing.
- Laurus Labs: Indian API and CDMO focused on small-molecule generics with global regulatory approvals. Directly comparable business model combining generic API manufacturing with custom synthesis services for global pharmaceutical customers.
- Hikal: Indian API and intermediates manufacturer with global regulatory approvals and pharma customer base. Similar scale and product focus on small-molecule APIs and advanced intermediates for regulated markets.
- Granules India: Indian API and finished dosage manufacturer with global regulatory approvals. Comparable in manufacturing generic APIs and intermediates for global pharmaceutical customers, with similar B2B GTM model.
Broad incumbents
- Dr. Reddy's Laboratories: Major Indian pharmaceutical company with significant API manufacturing operations alongside branded generics and biosimilars. Overlaps with Hy-Gro in API manufacturing but operates at much broader scale across the pharma value chain.
- Mankind Pharma: Large Indian pharmaceutical company with API manufacturing operations supporting domestic and export markets. Overlaps with Hy-Gro in API manufacturing but primarily focused on finished formulations.
- Piramal Pharma Solutions: Indian CDMO with significant API and intermediate manufacturing capabilities serving global pharma. Operates at larger scale but directly comparable in custom synthesis and toll manufacturing service offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Hy-Gro Chemicals Pharmtek social profiles
Digital presenceHy-Gro Chemicals Pharmtek compliance and trust
Trust signalCompliance12 records
Hy-Gro Chemicals Pharmtek financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hy-Gro Chemicals Pharmtek leadership team
Management profileNumber of profiles
Profiles1 record
Hy-Gro Chemicals Pharmtek funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hy-Gro Chemicals Pharmtek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hy-Gro Chemicals Pharmtek
What does Hy-Gro Chemicals Pharmtek do?
Hy-Gro Chemicals Pharmtek manufactures Active Pharmaceutical Ingredients (APIs), Advanced Intermediates, and Specialty fine chemicals at two cGMP-compliant facilities in India. The company supplies products such as Dextromethorphan Hydrobromide, Flurbiprofen, Naproxen, Naproxen Sodium, Doxylamine Succinate, Diflunisal, and Pyrathiazine Theoclate to global pharmaceutical companies, along with intermediates for molecules including Moxifloxacin, Levomepromazine, Dabigatran, Nelfinavir, Itraconazole, and Dapagliflozin. It also offers custom synthesis and toll manufacturing services for new products developed to customer specifications.
Is Hy-Gro Chemicals Pharmtek a public or private company?
Hy-Gro Chemicals Pharmtek is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Hy-Gro Chemicals Pharmtek founded?
Hy-Gro Chemicals Pharmtek was founded in 1970. It employs 11 to 50 people.
Where is Hy-Gro Chemicals Pharmtek based?
Hy-Gro Chemicals Pharmtek is headquartered in Secunderabad, India, in the Asia region.
How does Hy-Gro Chemicals Pharmtek make money?
Three revenue lines are on record. API Manufacturing and Sales are the primary driver. The others are advanced Intermediates Manufacturing and custom Synthesis and Toll Manufacturing.
Who are Hy-Gro Chemicals Pharmtek's main competitors?
Direct peers on record are Neuland Laboratories, Divis Laboratories, Aurobindo Pharma, Sai Life Sciences, Laurus Labs, Hikal and Granules India. Broad incumbents are Dr. Reddy's Laboratories, Mankind Pharma and Piramal Pharma Solutions.
Does Hy-Gro Chemicals Pharmtek have an API?
No public API is recorded for Hy-Gro Chemicals Pharmtek.
What industry is Hy-Gro Chemicals Pharmtek in?
Hy-Gro Chemicals Pharmtek's product category is Active Pharmaceutical Ingredients (APIs). Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 3254 and its SIC code is 2834.